36C25726Q0870_1.docx

36C25726Q0870

PAGE 1 OF

1. REQUISITION NO.

2. CONTRACT NO.

3. AWARD/EFFECTIVE DATE

4. ORDER NO.

5. SOLICITATION NUMBER

6. SOLICITATION ISSUE DATE

a. NAME

b. TELEPHONE NO. (No Collect Calls)

8. OFFER DUE DATE/LOCAL

TIME

9. ISSUED BY

CODE

10. THIS ACQUISITION IS

UNRESTRICTED OR

SET ASIDE:

% FOR:

SMALL BUSINESS

HUBZONE SMALL

BUSINESS

SERVICE-DISABLED

VETERAN-OWNED

SMALL BUSINESS

WOMEN-OWNED SMALL BUSINESS

(WOSB) ELIGIBLE UNDER THE WOMEN-OWNED

SMALL BUSINESS PROGRAM

EDWOSB

8(A)

NAICS:

SIZE STANDARD:

11. DELIVERY FOR FOB DESTINA-

TION UNLESS BLOCK IS

MARKED

SEE SCHEDULE

12. DISCOUNT TERMS

13a. THIS CONTRACT IS A

RATED ORDER UNDER

DPAS (15 CFR 700)

13b. RATING

14. METHOD OF SOLICITATION

RFQ

IFB

RFP

15. DELIVER TO

CODE

16. ADMINISTERED BY

CODE

17a. CONTRACTOR/OFFEROR

CODE

FACILITY CODE

18a. PAYMENT WILL BE MADE BY

CODE

TELEPHONE NO.

UEI:

EFT:

PHONE:

FAX:

17b. CHECK IF REMITTANCE IS DIFFERENT AND PUT SUCH ADDRESS IN OFFER 18b. SUBMIT INVOICES TO ADDRESS SHOWN IN BLOCK 18a UNLESS BLOCK BELOW IS CHECKED

SEE ADDENDUM

19.

20.

21.

22.

23.

24.

ITEM NO.

SCHEDULE OF SUPPLIES/SERVICES

QUANTITY

UNIT

UNIT PRICE

AMOUNT

(Use Reverse and/or Attach Additional Sheets as Necessary)

25. ACCOUNTING AND APPROPRIATION DATA

26. TOTAL AWARD AMOUNT (For Govt. Use Only) 27a. SOLICITATION INCORPORATES BY REFERENCE FAR 52.212-1, 52.212-4. FAR 52.212-3 AND 52.212-5 ARE ATTACHED. ADDENDA

ARE

ARE NOT ATTACHED.

27b. CONTRACT/PURCHASE ORDER INCORPORATES BY REFERENCE FAR 52.212-4. FAR 52.212-5 IS ATTACHED. ADDENDA

ARE

ARE NOT ATTACHED

28. CONTRACTOR IS REQUIRED TO SIGN THIS DOCUMENT AND RETURN _______________

29. AWARD OF CONTRACT: REF. ___________________________________ OFFER

COPIES TO ISSUING OFFICE. CONTRACTOR AGREES TO FURNISH AND

DATED ________________________________. YOUR OFFER ON SOLICITATION

DELIVER ALL ITEMS SET FORTH OR OTHERWISE IDENTIFIED ABOVE AND ON ANY

(BLOCK 5), INCLUDING ANY ADDITIONS OR CHANGES WHICH ARE

ADDITIONAL SHEETS SUBJECT TO THE TERMS AND CONDITIONS SPECIFIED

SET FORTH HEREIN IS ACCEPTED AS TO ITEMS:

30a. SIGNATURE OF OFFEROR/CONTRACTOR 31a. UNITED STATES OF AMERICA (SIGNATURE OF CONTRACTING OFFICER) 30b. NAME AND TITLE OF SIGNER (TYPE OR PRINT) 30c. DATE SIGNED 31b. NAME OF CONTRACTING OFFICER (TYPE OR PRINT) 31c. DATE SIGNED

AUTHORIZED FOR LOCAL REPRODUCTION

(REV. NOV 2021)

PREVIOUS EDITION IS NOT USABLE

Prescribed by GSA - FAR (48 CFR) 53.212

7. FOR SOLICITATION

INFORMATION CALL:

STANDARD FORM 1449

SOLICITATION/CONTRACT/ORDER FOR COMMERCIAL PRODUCTS AND COMMERCIAL SERVICES

OFFEROR TO COMPLETE BLOCKS 12, 17, 23, 24, & 30

08-28-2026 Teresa Arzola 2107403729 09-08-2026

9:00 AM

CDT

36C257 Department Of Veterans Affairs Network Contracting Office 17

5441 Babcock Road Ste. 302 San Antonio TX 78240

X

325413 1250 Employees

N/A X

36C549 Department of Veterans Affairs Dallas Texas Veterans Health Care System ATTN: Pathology & Laboratory Service 4500 S. Lancaster Rd.

Dallas TX 75216 36C671 Department Of Veterans Affairs Network Contracting Office 17

5441 Babcock Road Ste. 302 San Antonio TX 78240

This is accomplished through the Tungsten Network located at:

http://www.fsc.va.gov/einvoice.asp This is mandatory and the sole method for submitting invoices.

(877) 353-9791

(512) 460-5540

See CONTINUATION Page This solicitation is for Brand Name or Equal Blood Cost per test reagents.

Technical questions regarding this solicitation should be directed to Teresa Arzola, in writing at teresa.arzola@va.gov no later than 09/02/2026, 9:00AM CST.

See CONTINUATION Page x

Delphia Schoenfeld

Table of Contents

SECTION B - CONTINUATION OF SF 1449 BLOCKS

B.1 CONTRACT ADMINISTRATION DATA

1. Contract Administration: All contract administration matters will be handled by the following individuals:

a. CONTRACTOR:

b. GOVERNMENT: Contracting Officer 36C257 Department Of Veterans Affairs Network Contracting Office 17 5441 Babcock Road Ste. 302 San Antonio TX 78240

2. CONTRACTOR REMITTANCE ADDRESS: All payments by the Government to the contractor will be made in accordance with:

3. INVOICES: Invoices shall be submitted in arrears:

4. GOVERNMENT INVOICE ADDRESS: All Invoices from the contractor shall be submitted electronically in accordance with VAAR Clause 852.232-72 Electronic Submission of Payment Requests.

This is accomplished through Tungsten Network, located at: http://www.fsc.va.gov/einvoice/asp This is mandatory and the sole method for submitting invoices.

ACKNOWLEDGMENT OF AMENDMENTS: The offeror acknowledges receipt of amendments to the Solicitation numbered and dated as follows:

Page 1 of Page 1 of

B.2 STATEMENT OF WORK

1. Purpose: Transfusion Medicine Unit, Pathology and Laboratory Medicine Services (P&LMS) at the VA North Texas Health Care System (VANTHCS), Dallas, TX is seeking a fully automated gel instrument and reagents to perform Type & Screen testing with antibody ID panels, Direct Antiglobulin test, IS and AHG crossmatches and the capability to test for antigens.

Contract type will be cost per test with analyzer included.

WORK STATEMENT

2. Scope:

A. Provide an automated GEL analyzer to perform blood bank testing

a. Instrument must be gel technology that is compatible with the current government owned Ortho Workstations (Model Number 6904630).

b. Instrument must have designated options, all system software, monitor, printer, keyboard, technical support, customer training, and business hours service plan.

c. Instrument must be free standing or equipped with its own self-sustaining mobile stand.

d. Instruments must have minimally two independent centrifuges; desirably three centrifuges to facilitate efficiency of random loading of test.

e. The instrument must have the lowest technologist intervention maintenance time. Prefer predominant internal self-maintained instrumentation maintenance, the least interaction possible desired.

f. Instruments must have the capability to interface with the Laboratory information system(s).

g. The vendor must have an FDA-approved Quality Control product capable of successfully identifying ABO typing, Antibody Screens, and Rh Phenotyping.

B. Provide Reagents The Contractor shall provide reagents, consumables, and supplies as requested by VANTHCS staff to perform blood bank testing for the analyzer.

Quantities shown below are for annual requirements.

Group I –Yearly Test Volume:

Antibody Identification (with Selected Cell Panels capabilities)

Group II –Yearly Reagents & Consumables Requirements:

Group II –Yearly Traditional Reagents Requirements:

3. Location: The analyzer shall be located, and testing will be performed in Transfusion Medicine Unit, Room 1B-306, Pathology & Laboratory Medicine Service, VA North Texas Health Care System, 4500 S. Lancaster Rd., Dallas, TX 75216.

4. Delivery: Within 60 days of the contract award the vendor will deliver the analyzer and reagents to VA North Texas Health Care System, 4500 S. Lancaster Rd., Dallas, TX 75216.

5. Performance Requirements: The following are required:

A. Installation Requirements:

1) Deliver, install, and set up the instrument (automated analyzer) and components.

2) Deliver one manual testing platform (equipment)

3) Provide test validation guidance and validation supplies.

B. Testing Requirements:

1) ABO/RH

2) Antibody Screen (3 Cells)

3) Direct Antiglobulin Test (DAT)

4) Antibody Identification (with Selected Cell Panels Capabilities)

5) Immediate Spin Crossmatch

6) AHG Crossmatch

7) Antigen Testing Capabilities

8) Antibody Titration (with automated serial dilutions) Capabilities

C. System Requirements:

1) The system must contain continuous, random and STAT access technology.

2) The system must have minimal daily maintenance and tracking capabilities when maintenance has been completed.

3) The system should have technology to prevent sample carryover.

4) The system must feature error-proof reagent and commodity design with built-in safeguards to prevent reagent mix-ups, probe crashes and unnecessary downtime.

5) Sample carriers must be capable of utilizing different tube sizes in one carrier, thus avoiding the need for pre-analytic sorting.

6) The system must have automatic cap, clot and liquid level detection capabilities.

7) The system must not utilize proprietary system liquids.

8) The system must offer up to 24 hours of walkaway time.

9) When operational, the system must always be in a ready mode and at no time go into a hibernation or “sleep” state.

10) The system must be able to run selected cell antibody identification panels.

11) The optical resolution of the onboard camera must be at least 5-megapixel resolution down to 32 x 32 microns and store a digital image of both the front and back of each gel card to record test results.

12) A fully loaded waste container shall not weigh more than 11 lbs. and be accessible at waist height.

D. Connectivity Requirements: (Note: Does not use the following software: Windows XP Embedded Service Pack 3, Windows Server 2003 or Windows XP.)

1) System is fully interfaced (bidirectional) with VistA via Data Innovations: System accommodates reporting through Data Innovations (DI) to eliminate the need for manual data entry.

E. Maintenance:

1) The Contractor shall perform preventive maintenance at intervals specified by the manufacturer to ensure proper equipment performance. Preventive Maintenance includes the following:

a) Delivery of parts or materials for Preventive Maintenance.

b) Testing all components for proper test performance. Equipment shall reproduce results according to manufacturer’s specifications.

c) After Preventative Maintenance, the Contractor shall submit a detailed work report for notice at no additional cost.

d) The Contractor shall provide all preventive service materials at no additional cost to the government.

F. Technical Support:

1) Support Personnel will be available during business hours each business day, and live representatives via the Contractor’s message center will be available by telephone at all other times.

2) Technical support shall be available via telephone during business days (and by message center after hours) to provide troubleshooting assistance or to answer testing inquiries.

3) Responding Vendor is required to have 3 or more Field Engineers available 24/7/365 within one to two hour driving range of the facility.

4) On-site technical support shall be available for escalations within the next business day.

G. On-site Repairs:

1) For issues that the Contractor determines to require on-site support, the Contractor shall dispatch one or more Support Personnel, normally within next covered business day.

2) The Contractor shall submit a detailed work report to include all required materials.

3) The Contractor shall provide all parts and materials at no additional cost to the government.

4) The Contractor shall remove all parts, equipment or materials replaced or upgraded by the Contractor due to and not limited to repairs, replacements, recall, and upgrades without any cost to the government.

H. Training: The contractor shall provide the following:

1) Initial on-site operator training for the analyzer.

2) Handouts and training materials in sufficient quantity for each participant. These are off-the-shelf courses. The contractor shall provide lesson plan, course materials and media (DVD’s, CD’s, videos, etc. if required), and editable procedures at no additional cost.

3) Additional on-site training as requested by VANTHCS at no additional charge.

I. Safety:

1) The Contractor shall immediately notify VANTHCS of any changes in reagent kit composition, procedure modification, recall notification, or any changes that will affect the performance of the test or procedure according to FDA regulations.

J. Test Performance:

1) All tests, procedures, and equipment must be performed at manufacturer’s specifications. Deviations from the performance specifications shall be corrected by the Contractor.

2) Test performance will be evaluated by and not limited for performance through peer comparison, quality control and CAP peer evaluation.

6. Period of Performance: Cost per Test Agreement for the analyzer and reagents will be in effect for a contract year, with options to extend contract for four (4) additional one (1) year periods:

Base Year: September 15, 2026, through September 14, 2027 Option Year 1: September 15, 2027, through September 14, 2028 Option Year 2: September 15, 2028, through September 14, 2029 Option Year 3: September 15, 2029, through September 14, 2030 Option Year 4: September 15, 2030, through September 14, 2031 Contract includes FAR 52.217-8 The vendor shall remove all equipment within 90 days after notification of the expiration of the terms of this agreement but not until the completion of new vendor's equipment installation inclusive of completed cross over studies. Vendor shall be responsible for removing the hard drive and turning it over to the VANTHCS for destruction prior to removal of any analyzer.

7. Deliverables and Supplies: This order is for the cost per test procurement of an instrument/system for blood bank testing. Reagents and supplies will be purchased under the terms of the Federal Supply Schedules/GSA.

A. The Contractor shall deliver all supplies necessary for test performance at no Government cost.

B. The Contractor shall deliver all and not limited to operational, maintenance, troubleshooting, small repairs, equipment specifications, and test manuals.

C. The Contractor shall install the analyzer and perform test verification according to manufacturer specification and regulatory requirements.

D. The Contractor shall deliver one manual backup test platform (equipment) and provide necessary services for operation.

E. The Contractor shall provide supplies: reagents and consumables for test menu. Additional testing may be added at the discretion of VANTHCS.

F. In the event that requested supplies are on back-order, Contractor is to provide information as to the estimated time of availability.

G. The Contractor shall deliver all invoices for review according to the established contract at the end of each billing cycle.

H. All items not contracted shall be specifically detailed on the invoice including description, quantity acquired, and government cost.

I. Any changes in reagents or equipment modifications shall be immediately disclosed by the Contractor electronically as well as by postal mail with supporting documentation of the change, and detailed guidance for implementation within twenty-four hours of its application.

J. Additional charges incurred by the government to provide the continuity of contracted tests to patients and not limited to outsourcing, transportation, or any other additional cost shall be covered by the Contractor at no additional charge to the government.

8. Contractor Security Contract Requirements: This Contractor requires no access to VANTHCS or any VA information system. The analyzer will be interfaced to the VANTHCS information system through Data Innovations. There will be supervised access when the Contractor is physically present for technical support, service calls, and scheduled preventative maintenance.

VHA Handbook 6500.6

VA Information Security and Privacy language

1. GENERAL. This entire section applies to all acquisitions requiring any Information Security and Privacy language. Contractors, contractor personnel, subcontractors and subcontractor personnel will be subject to the same federal laws, regulations, standards, VA directives and handbooks, as VA personnel regarding information and information system security and privacy.

2. VA INFORMATION CUSTODIAL LANGUAGE. This entire section applies to all acquisitions requiring any Information Security and Privacy language.

a. Information made available to the contractor by VA for the performance or administration of this contract will be used only for the purposes specified in the service agreement, SOW, PWS, PD, and/or contract. The contractor shall not use VA information in any other manner without prior written approval from a VA Contracting Officer (CO). The primary clause used to define Government and Contractor data rights is FAR 52.227-14 Rights in Data – General.

b. VA information will not be co-mingled with any other data on the contractor’s information systems or media storage systems. The contractor shall ensure compliance with Federal and VA requirements related to data protection, data encryption, physical data segregation, logical data segregation, classification requirements and media sanitization.

c. VA reserves the right to conduct scheduled or unscheduled audits, assessments, or investigations of contractor Information Technology (IT) resources to ensure information security is compliant with Federal and VA requirements. The contractor shall provide all necessary access to records (including electronic and documentary materials related to the contracts and subcontracts) and support (including access to contractor and subcontractor staff associated with the contract) to VA, VA's Office Inspector General (OIG), and/or Government Accountability Office (GAO) staff during periodic control assessments, audits, or investigations.

d. The contractor may only use VA information within the terms of the contract and applicable Federal law, regulations, and VA policies. If new Federal information security laws, regulations or VA policies become applicable after execution of the contract, the parties agree to negotiate contract modification and adjustment necessary to implement the new laws, regulations, and/or policies.

e. The contractor shall not make copies of VA information except as specifically authorized and necessary to perform the terms of the contract. If copies are made for restoration purposes, after the restoration is complete, the copies shall be destroyed in accordance with VA Directive 6500, VA Cybersecurity Program and VA Information Security Knowledge Service.

f. The contractor’s firewall and web services security controls, as applicable, shall meet or exceed VA’s minimum requirements.

g. Except for uses and disclosures of VA information authorized by this contract for performance of the contract, the contractor may use and disclose VA information only in two situations: (i) in response to a qualifying order of a court of competent jurisdiction after notification to VA CO (ii) with written approval from the VA CO. The contractor shall refer all requests for demands for production of or inquiries about, VA information and information systems to the VA CO for response.

h. Information made available to the contractor by VA for the performance or administration of this contract or information developed by the contractor in performance or administration of the contract will be protected and secured in accordance with VA Directive 6500 and Identity and Access Management (IAM) Security processes specified in the VA Information Security Knowledge Service.

i. All electronic storage media (hard drives, optical disks, CDs, back-up tapes, etc.) used to store, process or access VA information will not be returned to the contractor at the end of lease, loan, or trade-in. Exceptions to this paragraph will only be granted with the written approval of VA CO.

SPECIALIZED DEVICES/SYSTEMS (MEDICAL DEVICES, SPECIAL PURPOSE

SYSTEMS, RESEARCH SCIENTIFIC COMPUTING). This entire section applies when the acquisition includes one or more Medical Device, Special Purpose System or Research Scientific Computing Device. If appropriate, ensure selected clauses from section 6 or 7 and 8 through 12 are included.

j. Contractor supplies/delivered Medical Devices, Special Purpose Systems- Operational Technology (SPS-OT) and Research Scientific Computing Devices shall comply with all applicable Federal law, regulations, and VA policies. New developments require creation, testing, evaluation, and authorization in compliance with processes specified on the Specialized Device Cybersecurity Department Enterprise Risk Management (SDCD-ERM) Portal, VA Directive 6550, Pre-Procurement Assessment and Implementation of Medical Devices/Systems, VA Handbook 6500, and the VA Information Security Knowledge Service. Deviations from Federal law, regulations, and VA Policy are identified and documented as part of VA Directive 6550 and/or the VA Enterprise Risk Analysis (ERA) processes for Specialized Devices/Systems processes.

k. All contractors and third-party service providers shall address and/or integrate applicable VA Handbook 6500 and Information Security Knowledge Service specifications in delivered IT systems/solutions, products and/or services. If systems/solutions, products and/or services do not directly match VA security requirements, the contractor shall work though the COR/CO for governance or resolution.

l. The contractor shall certify to the COR/CO that devices/systems that have completed the VA Enterprise Risk Analysis (ERA) process for Specialized Devices/Systems are fully functional and operate correctly as intended. Devices/systems must follow the VA ERA authorized configuration prior to acquisition and connection to the VA computing environment. If VA determines a new VA ERA needs to be created, the contractor shall provide required technical support to develop the configuration settings. Major changes to a previously approved device/system will require a new ERA.

m. The contractor shall comply with all practices documented by the Food Drug and Administration (FDA) Premarket Submission for Management of Cybersecurity in Medical Devices and Postmarket Management of Cybersecurity in Medical Devices.

n. The contractor shall provide devices able to install and maintain VA-approved antivirus capabilities with the capability to quarantine files and be updated as needed in response to incidents. Alternatively, a VA-approved whitelisting application may be used when the contractor cannot install an anti-virus / anti- malware application.

o. The contractor shall verify and document all software embedded within the device does not contain any known viruses or malware before delivery to or installation at a VA location.

p. Devices and other equipment or systems containing media (hard drives, optical disks, solid state, and storage via chips/firmware) with VA sensitive information will be returned to the contractor with media removed. When the contract requires return of equipment, the options available to the contractor are the following:

(1) The contractor shall accept the system without the drive, firmware and solid state.

(2) VA’s initial device purchase includes a spare drive or other replacement media which must be installed in place of the original drive at time of turn- in; or

(3) Due to the highly specialized and sometimes proprietary hardware and software associated with the device, if it is not possible for VA to retain the hard drive, firmware, and solid state, then:

(a) The equipment contractor shall have an existing BAA if the device being traded in has sensitive information stored on it and hard drive(s) from the system are being returned physically intact.

(b) Any fixed hard drive, Complementary Metal-Oxide-Semiconductor (CMOS), Programmable Read-Only Memory (PROM), solid state and firmware on the device must be non-destructively sanitized to the greatest extent possible without negatively impacting system operation. Selective clearing down to patient data folder level is recommended using VA approved and validated overwriting technologies/methods/tools. Applicable media sanitization specifications need to be pre-approved and described in the solicitation, contract, or order.

NO VA DATA OF ANY TYPE SHALL BE TRANSFERRED FROM THE VA.

Privacy

1. Contractors and subcontractors must adhere to the provisions of Public Law 104-191, Health Insurance Portability and Accountability Act (HIPAA) of 1996. This includes both the Privacy and Security Rules published by the Department of Health and Human Services (HHS).

2. As required by HIPAA, HHS has promulgated rules governing the use and disclosure of protected health information by covered entities, Veterans Health Administration (VHA). In accordance with HIPAA, the contractor may be required to enter into a Business Associate Agreement (BAA) with VHA.

3. Business associates must follow VHA privacy policies and practices when applicable. All contractors and business associates must receive privacy training annually.

4. For contractors and business associates who do not have access to VHA computer systems, this requirement is met by completing VHA National Privacy Policy training, other VHA approved privacy training or contractor furnished training that meets the requirements of the HHS Standards for Privacy of Individually Identifiable Health Information as determined by VHA.

5. For contractors and business associates who are granted access to VHA computer systems, this requirement is met by completing VHA National Privacy Policy training or other VHA approved privacy training. Proof of training is required upon request.

NARA Records Management Language for Contracts (May 2017)

1. Contractor shall comply with all applicable records management laws and regulations, as well as National Archives and Records Administration (NARA) records policies, including but not limited to the Federal Records Act (44 U.S.C. chs. 21, 29, 31, 33), NARA regulations at 36 CFR Chapter XII Subchapter B, and those policies associated with the safeguarding of records covered by the Privacy Act of 1974 (5 U.S.C. 552a). These policies include the preservation of all records, regardless of form or characteristics, mode of transmission, or state of completion.

2. In accordance with 36 CFR 1222.32, all data created for Government use and delivered to, or falling under the legal control of, the Government are Federal records subject to the provisions of 44 U.S.C. chapters 21, 29, 31, and 33, the Freedom of Information Act (FOIA) (5 U.S.C. 552), as amended, and the Privacy Act of 1974 (5 U.S.C. 552a), as amended and must be managed and scheduled for disposition only as permitted by statute or regulation.

3. In accordance with 36 CFR 1222.32, Contractor shall maintain all records created for Government use or created in the course of performing the contract and/or delivered to, or under the legal control of the Government and must be managed in accordance with Federal law. Electronic records and associated metadata must be accompanied by sufficient technical documentation to permit understanding and use of the records and data.

4. VA North Texas Health Care System and its contractors are responsible for preventing the alienation or unauthorized destruction of records, including all forms of mutilation. Records may not be removed from the legal custody of VA North Texas Health Care System or destroyed except for in accordance with the provisions of the agency records schedules and with the written concurrence of the Head of the Contracting Activity. Willful and unlawful destruction, damage or alienation of Federal records is subject to the fines and penalties imposed by 18 U.S.C. 2701.

In the event of any unlawful or accidental removal, defacing, alteration, or destruction of records, Contractor must report to VA North Texas Health Care System. The agency must report promptly to NARA in accordance with 36 CFR 1230.

5. The Contractor shall immediately notify the appropriate Contracting Officer upon discovery of any inadvertent or unauthorized disclosures of information, data, documentary materials, records or equipment. Disclosure of non-public information is limited to authorized personnel with a need-to-know as described in the [contract vehicle]. The Contractor shall ensure that the appropriate personnel, administrative, technical, and physical safeguards are established to ensure the security and confidentiality of this information, data, documentary material, records and/or equipment is properly protected. The Contractor shall not remove material from Government facilities or systems, or facilities or systems operated or maintained on the Government’s behalf, without the express written permission of the Head of the Contracting Activity. When information, data, documentary material, records and/or equipment is no longer required, it shall be returned to VA North Texas Health Care System control or the Contractor must hold it until otherwise directed. Items returned to the Government shall be hand carried, mailed, emailed, or securely electronically transmitted to the Contracting Officer or address prescribed in the [contract vehicle]. Destruction of records is EXPRESSLY PROHIBITED unless in accordance with Paragraph (4).

6. The Contractor is required to obtain the Contracting Officer's approval prior to engaging in any contractual relationship (sub-contractor) in support of this contract requiring the disclosure of information, documentary material and/or records generated under, or relating to, contracts. The Contractor (and any sub-contractor) is required to abide by Government and VA North Texas Health Care System guidance for protecting sensitive, proprietary information, classified, and controlled unclassified information.

7. The Contractor shall only use Government IT equipment for purposes specifically tied to or authorized by the contract and in accordance with VA North Texas Health Care System policy.

8. The Contractor shall not create or maintain any records containing any non-public VA North Texas Health Care System information that are not specifically tied to or authorized by the contract.

9. The Contractor shall not retain, use, sell, or disseminate copies of any deliverable that contains information covered by the Privacy Act of 1974 or that which is generally protected from public disclosure by an exemption to the Freedom of Information Act.

10. The VA North Texas Health Care System owns the rights to all data and records produced as part of this contract. All deliverables under the contract are the property of the U.S. Government for which VA North Texas Health Care System shall have unlimited rights to use, dispose of, or disclose such data contained therein as it determines to be in the public interest. Any Contractor rights in the data or deliverables must be identified as required by FAR 52.227-11 through FAR 52.227-20.

11. Training: All Contractor employees assigned to this contract who create, work with, or otherwise handle records are required to take VHA-provided records management training, Talent Management System (TMS) Item #3873736, Records Management for Records Officers and Liaisons. The Contractor is responsible for confirming training has been completed according to agency policies, including initial training and any annual or refresher training.

B.3 PRICE/COST SCHEDULE

NOTE: ALL ITEMS ARE BRAND NAME OR EQUAL

ITEM INFORMATION

MTS A/B Group, MTS080017 Contract Period: Base POP Begin: 09-15-2026 POP End: 09-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing PRODUCT/SERVICE CODE: 6550 - In Vitro Diagnostic Substances, Reagents, Test Kits and Sets

MANUFACTURER PART NUMBER (MPN): MTS080017

MTS A/B/D Group, MTS081115

POP Begin: 09-15-2026 POP End: 09-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MANUFACTURER PART NUMBER (MPN): MTS081115

MTS A/B/D Mono & Reverse Grp Card, MTS080515

POP Begin: 09-15-2026 POP End: 09-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MANUFACTURER PART NUMBER (MPN): MTS080515

MTS DAT Card, MTS601402

POP Begin: 09-15-2026 POP End: 09-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MANUFACTURER PART NUMBER (MPN): MTS601402

MTS Anti-IgG Card, MTS084024

POP Begin: 09-15-2026 POP End: 09-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MANUFACTURER PART NUMBER (MPN): MTS084024

MTS Buffered Gel Card, MTS085014

POP Begin: 09-15-2026 POP End: 09-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MANUFACTURER PART NUMBER (MPN): MTS085014

7% BSA, 6844285

POP Begin: 09-15-2026 POP End: 09-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MANUFACTURER PART NUMBER (MPN): 6844285

OV Evaporation Caps - 10mL, 6843005

POP Begin: 09-15-2026 POP End: 09-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MANUFACTURER PART NUMBER (MPN): 6843005

MTS Diluent 2, MTS9230

POP Begin: 09-15-2026 POP End: 09-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MANUFACTURER PART NUMBER (MPN): MTS9230

MTS Diluent 2 Plus, MTS9330

POP Begin: 09-15-2026 POP End: 09-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MANUFACTURER PART NUMBER (MPN): MTS9330

0.8% Affirmagen, 719201

POP Begin: 09-15-2026 POP End: 09-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MANUFACTURER PART NUMBER (MPN): 719201

0.8% RESOLVE Panel B, 6902318

POP Begin: 09-15-2026 POP End: 09-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MANUFACTURER PART NUMBER (MPN): 6902318

0.8% RESOLVE Panel C, 6902319

POP Begin: 09-15-2026 POP End: 09-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MANUFACTURER PART NUMBER (MPN): 6902319

0.8% Surgiscreen, 6902316

POP Begin: 09-15-2026 POP End: 09-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MANUFACTURER PART NUMBER (MPN): 6902316

ORTHO Daily QC Kit, 6708858

POP Begin: 09-15-2026 POP End: 09-14-2027 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MANUFACTURER PART NUMBER (MPN): 6708858

MTS A/B Group, MTS080017 Contract Period: Option 1 POP Begin: 09-15-2027 POP End: 09-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS A/B/D Group, MTS081115

POP Begin: 09-15-2027 POP End: 09-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS A/B/D Mono & Reverse Grp Card, MTS080515

POP Begin: 09-15-2027 POP End: 09-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS DAT Card, MTS601402

POP Begin: 09-15-2027 POP End: 09-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS Anti-IgG Card, MTS084024

POP Begin: 09-15-2027 POP End: 09-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS Buffered Gel Card, MTS085014

POP Begin: 09-15-2027 POP End: 09-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

7% BSA, 6844285

POP Begin: 09-15-2027 POP End: 09-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OV Evaporation Caps - 10mL, 6843005

POP Begin: 09-15-2027 POP End: 09-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS Diluent 2, MTS9230

POP Begin: 09-15-2027 POP End: 09-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS Diluent 2 Plus, MTS9330

POP Begin: 09-15-2027 POP End: 09-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0.8% Affirmagen, 719201

POP Begin: 09-15-2027 POP End: 09-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0.8% RESOLVE Panel B, 6902318

POP Begin: 09-15-2027 POP End: 09-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0.8% RESOLVE Panel C, 6902319

POP Begin: 09-15-2027 POP End: 09-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0.8% Surgiscreen, 6902316

POP Begin: 09-15-2027 POP End: 09-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

ORTHO Daily QC Kit, 6708858

POP Begin: 09-15-2027 POP End: 09-14-2028 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS A/B Group, MTS080017 Contract Period: Option 2 POP Begin: 09-15-2028 POP End: 09-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS A/B/D Group, MTS081115

POP Begin: 09-15-2028 POP End: 09-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS A/B/D Mono & Reverse Grp Card, MTS080515

POP Begin: 09-15-2028 POP End: 09-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS DAT Card, MTS601402

POP Begin: 09-15-2028 POP End: 09-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS Anti-IgG Card, MTS084024

POP Begin: 09-15-2028 POP End: 09-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS Buffered Gel Card, MTS085014

POP Begin: 09-15-2028 POP End: 09-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

7% BSA, 6844285

POP Begin: 09-15-2028 POP End: 09-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OV Evaporation Caps - 10mL, 6843005

POP Begin: 09-15-2028 POP End: 09-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS Diluent 2, MTS9230

POP Begin: 09-15-2028 POP End: 09-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS Diluent 2 Plus, MTS9330

POP Begin: 09-15-2028 POP End: 09-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0.8% Affirmagen, 719201

POP Begin: 09-15-2028 POP End: 09-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0.8% RESOLVE Panel B, 6902318

POP Begin: 09-15-2028 POP End: 09-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0.8% RESOLVE Panel C, 6902319

POP Begin: 09-15-2028 POP End: 09-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0.8% Surgiscreen, 6902316

POP Begin: 09-15-2028 POP End: 09-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

ORTHO Daily QC Kit, 6708858

POP Begin: 09-15-2028 POP End: 09-14-2029 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS A/B Group, MTS080017 Contract Period: Option 3 POP Begin: 09-15-2029 POP End: 09-14-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS A/B/D Group, MTS081115

POP Begin: 09-15-2029 POP End: 09-14-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS A/B/D Mono & Reverse Grp Card, MTS080515

POP Begin: 09-15-2029 POP End: 09-14-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS DAT Card, MTS601402

POP Begin: 09-15-2029 POP End: 09-14-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS Anti-IgG Card, MTS084024

POP Begin: 09-15-2029 POP End: 09-14-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS Buffered Gel Card, MTS085014

POP Begin: 09-15-2029 POP End: 09-14-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

7% BSA, 6844285

POP Begin: 09-15-2029 POP End: 09-14-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OV Evaporation Caps - 10mL, 6843005

POP Begin: 09-15-2029 POP End: 09-14-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS Diluent 2, MTS9230

POP Begin: 09-15-2029 POP End: 09-14-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS Diluent 2 Plus, MTS9330

POP Begin: 09-15-2029 POP End: 09-14-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0.8% Affirmagen, 719201

POP Begin: 09-15-2029 POP End: 09-14-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0.8% RESOLVE Panel B, 6902318

POP Begin: 09-15-2029 POP End: 09-14-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0.8% RESOLVE Panel C, 6902319

POP Begin: 09-15-2029 POP End: 09-14-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0.8% Surgiscreen, 6902316

POP Begin: 09-15-2029 POP End: 09-14-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

ORTHO Daily QC Kit, 6708858

POP Begin: 09-15-2029 POP End: 09-14-2030 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS A/B Group, MTS080017 Contract Period: Option 4 POP Begin: 09-15-2030 POP End: 09-14-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS A/B/D Group, MTS081115

POP Begin: 09-15-2030 POP End: 09-14-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS A/B/D Mono & Reverse Grp Card, MTS080515

POP Begin: 09-15-2030 POP End: 09-14-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS DAT Card, MTS601402

POP Begin: 09-15-2030 POP End: 09-14-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS Anti-IgG Card, MTS084024

POP Begin: 09-15-2030 POP End: 09-14-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS Buffered Gel Card, MTS085014

POP Begin: 09-15-2030 POP End: 09-14-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

7% BSA, 6844285

POP Begin: 09-15-2030 POP End: 09-14-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

OV Evaporation Caps - 10mL, 6843005

POP Begin: 09-15-2030 POP End: 09-14-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS Diluent 2, MTS9230

POP Begin: 09-15-2030 POP End: 09-14-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

MTS Diluent 2 Plus, MTS9330

POP Begin: 09-15-2030 POP End: 09-14-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0.8% Affirmagen, 719201

POP Begin: 09-15-2030 POP End: 09-14-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0.8% RESOLVE Panel B, 6902318

POP Begin: 09-15-2030 POP End: 09-14-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0.8% RESOLVE Panel C, 6902319

POP Begin: 09-15-2030 POP End: 09-14-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

0.8% Surgiscreen, 6902316

POP Begin: 09-15-2030 POP End: 09-14-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

ORTHO Daily QC Kit, 6708858

POP Begin: 09-15-2030 POP End: 09-14-2031 PRINCIPAL NAICS CODE: 325413 - In-Vitro Diagnostic Substance Manufacturing

B.4 DELIVERY SCHEDULE

Dallas VA Health Care System 4500 S. Lancaster RD Dallas, TX 75216

USA

Dallas VA Health Care System 4500 S. Lancaster RD Dallas, TX 75216

USA

Dallas VA Health Care System 4500 S. Lancaster RD Dallas, TX 75216

USA

Dallas VA Health Care System 4500 S. Lancaster RD Dallas, TX 75216

USA

Dallas VA Health Care System 4500 S. Lancaster RD Dallas, TX 75216

USA

SECTION C - CONTRACT CLAUSES

C.1 52.252-2 CLAUSES INCORPORATED BY REFERENCE (FEB 1998)

This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this/these address(es):

https://www.acquisition.gov/browse/index/far https://www.va.gov/oal/library/vaar/

(End of Clause)